BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37792639)

  • 1. Risk factors for unresectable pancreatic cancer following high-intensity focused ultrasound treatment.
    Yang Y; Shi XQ; Chen G; Qian LX
    Cancer Med; 2023 Oct; 12(19):19537-19547. PubMed ID: 37792639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity.
    Marinova M; Rauch M; Mücke M; Rolke R; Gonzalez-Carmona MA; Henseler J; Cuhls H; Radbruch L; Strassburg CP; Zhang L; Schild HH; Strunk HM
    Eur Radiol; 2016 Nov; 26(11):4047-4056. PubMed ID: 26886904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer.
    Li PZ; Zhu SH; He W; Zhu LY; Liu SP; Liu Y; Wang GH; Ye F
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):655-60. PubMed ID: 23232639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of survival factors of high intensity focused ultrasound (HIFU) treatment for unresectable pancreatic cancer.
    Ning ZY; Cheng CS; Xie J; Chen QW; Xu LT; Zhuang LP; Zhang CY; Song LB; Shi WD; Zhu XY; Wang P; Wang K; Meng ZQ
    Discov Med; 2016 Jun; 21(118):435-45. PubMed ID: 27448780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Intensity Focused Ultrasound Ablation for Patients With Locally Advanced Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis.
    Ning J; Wang S; Guo Y; Diao J; Bai X; Wang H; Hu K; Zhao Q
    J Ultrasound Med; 2023 Jul; 42(7):1595-1607. PubMed ID: 36691925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound for evaluating response to pulsed-wave high-intensity focused ultrasound therapy in advanced pancreatic cancer.
    Yang Y; Shi XQ; Chen G; Zhou XN; Qian LX
    Clin Hemorheol Microcirc; 2022; 81(1):57-67. PubMed ID: 35001881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Use of High-Intensity Focused Ultrasound (HIFU) for Tumor and Pain Reduction in Advanced Pancreatic Cancer.
    Strunk HM; Henseler J; Rauch M; Mücke M; Kukuk G; Cuhls H; Radbruch L; Zhang L; Schild HH; Marinova M
    Rofo; 2016 Jul; 188(7):662-70. PubMed ID: 27272685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Pancreatic Cancer: High-Intensity Focused Ultrasound (HIFU) and Other Local Ablative Therapies.
    Marinova M; Wilhelm-Buchstab T; Strunk H
    Rofo; 2019 Mar; 191(3):216-227. PubMed ID: 30703824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving quality of life in pancreatic cancer patients following high-intensity focused ultrasound (HIFU) in two European centers.
    Marinova M; Feradova H; Gonzalez-Carmona MA; Conrad R; Tonguc T; Thudium M; Becher MU; Kun Z; Gorchev G; Tomov S; Strassburg CP; Attenberger U; Schild HH; Dimitrov D; Strunk HM
    Eur Radiol; 2021 Aug; 31(8):5818-5829. PubMed ID: 33486605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy.
    Sofuni A; Asai Y; Tsuchiya T; Ishii K; Tanaka R; Tonozuka R; Honjo M; Mukai S; Nagai K; Yamamoto K; Matsunami Y; Kurosawa T; Kojima H; Homma T; Minami H; Nakatsubo R; Hirakawa N; Miyazawa H; Nagakawa Y; Tsuchida A; Itoi T
    Curr Oncol; 2021 Nov; 28(6):4845-4861. PubMed ID: 34898585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for patients with locally advanced pancreatic cancer.
    Fergadi MP; Magouliotis DE; Rountas C; Vlychou M; Athanasiou T; Symeonidis D; Pappa PA; Zacharoulis D
    Abdom Radiol (NY); 2022 Jan; 47(1):254-264. PubMed ID: 34718835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of a new high intensity focused ultrasound therapy for locally advanced pancreatic cancer.
    Zhao J; Zhao F; Shi Y; Deng Y; Hu X; Shen H
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):2105-2111. PubMed ID: 28620685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of dynamic contrast enhanced ultrasound (DCE-US) in monitoring treatment effect of high-intensity focused ultrasound (HIFU) in locally advanced pancreatic cancer (LAPC).
    Zuo D; Feng Y; Zhang Q; Qiu YJ; Tian XF; Shi SN; Dong Y; Liu TS; Wang WP
    Clin Hemorheol Microcirc; 2021; 77(3):323-333. PubMed ID: 33252067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US-guided high-intensity focused ultrasound in pancreatic cancer treatment: a consensus initiative between Chinese and European HIFU centers.
    Zhou K; Strunk H; Dimitrov D; Vidal-Jove J; Gonzalez-Carmona MA; Essler M; Jin C; Mei Z; Zhu H; Marinova M
    Int J Hyperthermia; 2024; 41(1):2295812. PubMed ID: 38159562
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultrasound Guided High Intensity Focused Ultrasound for malignant tumors: The Spanish experience of survival advantage in stage III and IV pancreatic cancer.
    Vidal-Jove J; Perich E; Del Castillo MA
    Ultrason Sonochem; 2015 Nov; 27():703-706. PubMed ID: 26044461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of a new high-intensity focused ultrasound therapy for metastatic pancreatic cancer.
    Zhao J; Shen H; Hu X; Wang Y; Yuan Y
    Int J Hyperthermia; 2021; 38(1):288-295. PubMed ID: 33615955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-intensity focused ultrasound (HIFU) for tumor pain relief in inoperable pancreatic cancer : Evaluation with the pain sensation scale (SES)].
    Marinova M; Strunk HM; Rauch M; Henseler J; Clarens T; Brüx L; Dolscheid-Pommerich R; Conrad R; Cuhls H; Radbruch L; Schild HH; Mücke M
    Schmerz; 2017 Feb; 31(1):31-39. PubMed ID: 27402264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-intensity focused ultrasound ablation for advanced pancreatic cancer.
    Zhu B; Li J; Diao L; Ma K; Fan Y; Yang W
    J Cancer Res Ther; 2019; 15(4):831-835. PubMed ID: 31436239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.
    Wang G; Zhou D
    Ultrason Sonochem; 2015 Nov; 27():694-702. PubMed ID: 26113389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer.
    Sofuni A; Moriyasu F; Sano T; Itokawa F; Tsuchiya T; Kurihara T; Ishii K; Tsuji S; Ikeuchi N; Tanaka R; Umeda J; Tonozuka R; Honjo M; Mukai S; Fujita M; Itoi T
    World J Gastroenterol; 2014 Jul; 20(28):9570-7. PubMed ID: 25071354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.